| Robert James Blair Macaulay, MD | |
|
12902 Usf Magnolia Dr, Rm 2034g, Tampa, FL 33612-9416 | |
| (813) 745-3150 | |
| Not Available |
| Full Name | Robert James Blair Macaulay |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 36 Years |
| Location | 12902 Usf Magnolia Dr, Tampa, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083022743 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZN0500X | Pathology - Neuropathology | ME121011 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc | 2264337021 | 920 |
News Archive
Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.
Research published by scientists at the University of California, Riverside on "fear memory" could lead to the development of therapies that reduce the effects of post-traumatic stress disorder (PTSD).
Gen-Probe Incorporated announced today that Health Canada has granted the Company a medical device license for the PANTHER system, a fully automated and integrated molecular testing system designed with the flexibility to handle a wide range of testing needs.
NCR Corporation reported financial results today for the three months ended December 31, 2010. Reported revenue of $1.4 billion increased 5 percent from the fourth quarter of 2009 on both an actual and constant currency basis.
Many marketing studies have examined the impact of direct-to-consumer advertising of pharmaceuticals on sales and market shares. But in a new study, a researcher from The University of Texas at Dallas wanted to know whether drug advertising might have some unintended, population-level health consequences.
› Verified 4 days ago
| Entity Name | H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306833595 PECOS PAC ID: 2264337021 Enrollment ID: O20031204000575 |
News Archive
Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.
Research published by scientists at the University of California, Riverside on "fear memory" could lead to the development of therapies that reduce the effects of post-traumatic stress disorder (PTSD).
Gen-Probe Incorporated announced today that Health Canada has granted the Company a medical device license for the PANTHER system, a fully automated and integrated molecular testing system designed with the flexibility to handle a wide range of testing needs.
NCR Corporation reported financial results today for the three months ended December 31, 2010. Reported revenue of $1.4 billion increased 5 percent from the fourth quarter of 2009 on both an actual and constant currency basis.
Many marketing studies have examined the impact of direct-to-consumer advertising of pharmaceuticals on sales and market shares. But in a new study, a researcher from The University of Texas at Dallas wanted to know whether drug advertising might have some unintended, population-level health consequences.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert James Blair Macaulay, MD 12902 Usf Magnolia Dr, Rm 2034g, Tampa, FL 33612-9416 Ph: (813) 745-3150 | Robert James Blair Macaulay, MD 12902 Usf Magnolia Dr, Rm 2034g, Tampa, FL 33612-9416 Ph: (813) 745-3150 |
News Archive
Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated as monotherapy, adjuvant therapy and combination therapy for certain types of breast, colon and colorectal cancers.
Research published by scientists at the University of California, Riverside on "fear memory" could lead to the development of therapies that reduce the effects of post-traumatic stress disorder (PTSD).
Gen-Probe Incorporated announced today that Health Canada has granted the Company a medical device license for the PANTHER system, a fully automated and integrated molecular testing system designed with the flexibility to handle a wide range of testing needs.
NCR Corporation reported financial results today for the three months ended December 31, 2010. Reported revenue of $1.4 billion increased 5 percent from the fourth quarter of 2009 on both an actual and constant currency basis.
Many marketing studies have examined the impact of direct-to-consumer advertising of pharmaceuticals on sales and market shares. But in a new study, a researcher from The University of Texas at Dallas wanted to know whether drug advertising might have some unintended, population-level health consequences.
› Verified 4 days ago
Dr. Ifeanyi Victor Nwadukwe, M.D Pathology Medicare: Accepting Medicare Assignments Practice Location: 5481 W Waters Ave Ste 111, Tampa, FL 33634 Phone: 813-577-4686 | |
Dr. Theresa A Boyle, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 12902 Magnolia Dr, Moffitt Cancer Center, Tampa, FL 33612 Phone: 813-745-4673 | |
Joseph Andrew Migliozzi, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 9812 Compass Point Way, Tampa, FL 33615 Phone: 813-495-6268 Fax: 813-876-2507 | |
Dr. Steven John Agosti, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 13000 Bruce B Downs Blvd, P&lm Service (113), Jah Va Hospital, Tampa, FL 33612 Phone: 813-972-2000 Fax: 813-978-5827 | |
Dr. Sarah Booker Hugar, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 5481 W Waters Ave, Tampa, FL 33634 Phone: 813-577-4686 | |
Andrew A Borkowski, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 13000 Bruce B Downs Blvd, Tampa, FL 33612 Phone: 813-972-7525 Fax: 813-978-5827 | |
Thora Steffensen, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 5751 Hoover Blvd, Tampa, FL 33634 Phone: 813-886-8334 |